BRAF-inhibitors are powerful drugs and are known to be crucial for melanoma patients. The BRAF's protein power can be turned off by the inhibitors, resulting in a spur of cancer cell growth. Yet these inhibitors often work for only a year or less. Scientists know some of the DNA mutations that cause the drug resistance, but scientists have not been able to determine the underlying cause of the resistance in as many as a third of these patients. As a result, identifying ...
http://ift.tt/1zcpYyy
http://ift.tt/1BWgEAm
No comments:
Post a Comment